These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14670691)

  • 21. Significant, but limited collateral blood flow increases occur with prolonged training in rats with femoral artery occlusion.
    Prior BM; Ren J; Terjung RL; Yang HT
    J Physiol Pharmacol; 2011 Apr; 62(2):197-205. PubMed ID: 21673368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exaggerated cardiovascular responses to treadmill running in rats with peripheral arterial insufficiency.
    Kuczmarski JM; Unrath K; Thomas GD
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H114-H121. PubMed ID: 28986360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease.
    Paumier A; Abraham P; Mahé G; Maugin E; Enon B; Leftheriotis G; Picquet J
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):323-9. PubMed ID: 19910224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
    Regensteiner JG; Stewart KJ
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A; Shibata R; Morisaki K; Murohara T; Komori K
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol for Intermittent Claudication Caused by Peripheral Artery Disease.
    Lauters R; Wilkin D
    Am Fam Physician; 2022 Apr; 105(4):366-367. PubMed ID: 35426633
    [No Abstract]   [Full Text] [Related]  

  • 29. Cilostazol treatment of claudication in diabetic patients.
    Rendell M; Cariski AT; Hittel N; Zhang P
    Curr Med Res Opin; 2002; 18(8):479-87. PubMed ID: 12564659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of proximal claudication among patients with patent aortobifemoral bypasses.
    Jaquinandi V; Picquet J; Bouyé P; Saumet JL; Leftheriotis G; Abraham P
    J Vasc Surg; 2007 Feb; 45(2):312-8. PubMed ID: 17264010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol.
    Nakai K; Takenobu Y; Takimizu H; Akimaru S; Maegawa H; Ito H; Marsala M; Katsube N
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):253-63. PubMed ID: 14518565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM; Virgini-Magalhães CE; Lencastre Sicuro F; Bottino DA; Bouskela E
    Angiology; 2008; 59(5):549-58. PubMed ID: 18388031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endovascular model of rabbit hindlimb ischemia: a platform to evaluate therapeutic angiogenesis.
    Liddell RP; Patel TH; Weiss CR; Lee DS; Matsuhashi T; Brown PR; Gabrielson KL; Rodriguez ER; Eng J; Kimura H; Hofmann LV
    J Vasc Interv Radiol; 2005 Jul; 16(7):991-8. PubMed ID: 16002507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cilostazol in the treatment of intermittent claudication.
    Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
    Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery.
    Jaquinandi V; Picquet J; Saumet JL; Benharash P; Leftheriotis G; Abraham P
    Ann Surg; 2008 May; 247(5):869-76. PubMed ID: 18438126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
    Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia.
    Tang GL; Chang DS; Sarkar R; Wang R; Messina LM
    J Vasc Surg; 2005 Feb; 41(2):312-20. PubMed ID: 15768015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging-based monitoring of collateral artery development in patients with intermittent claudication during supervised exercise therapy.
    Versluis B; Leiner T; Nelemans PJ; Wildberger JE; Schurink GW; Backes WH
    J Vasc Surg; 2013 Nov; 58(5):1236-43. PubMed ID: 23522901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).
    Hiatt WR; Money SR; Brass EP
    J Vasc Surg; 2008 Feb; 47(2):330-336. PubMed ID: 18155871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.